4/24
01:32 am
abt
Abbott Laboratories (NYSE: ABT) had its "buy" rating re-affirmed by analysts at Raymond James. They now have a $124.00 price target on the stock.
Low
Report
Abbott Laboratories (NYSE: ABT) had its "buy" rating re-affirmed by analysts at Raymond James. They now have a $124.00 price target on the stock.
4/24
01:32 am
abt
Abbott Laboratories (NYSE: ABT) had its "buy" rating re-affirmed by analysts at Raymond James. They now have a $124.00 price target on the stock.
Low
Report
Abbott Laboratories (NYSE: ABT) had its "buy" rating re-affirmed by analysts at Raymond James. They now have a $124.00 price target on the stock.
4/22
08:35 am
abt
Rating for ABT
Low
Report
Rating for ABT
4/22
08:35 am
abt
Rating for ABT
Low
Report
Rating for ABT
4/18
11:52 am
abt
Rating for ABT
Low
Report
Rating for ABT
4/18
11:52 am
abt
Rating for ABT
Low
Report
Rating for ABT
4/4
12:17 pm
abt
Rating for ABT
Low
Report
Rating for ABT
4/3
11:31 am
abt
Rating for ABT
Low
Report
Rating for ABT
4/3
11:31 am
abt
Rating for ABT
Low
Report
Rating for ABT
2/14
10:22 am
abt
Abbott Laboratories (NYSE: ABT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $128.00 price target on the stock.
Low
Report
Abbott Laboratories (NYSE: ABT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $128.00 price target on the stock.
2/14
10:22 am
abt
Abbott Laboratories (NYSE: ABT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $128.00 price target on the stock.
Low
Report
Abbott Laboratories (NYSE: ABT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $128.00 price target on the stock.
2/14
09:48 am
abt
Rating for ABT
Low
Report
Rating for ABT
2/14
09:48 am
abt
Rating for ABT
Low
Report
Rating for ABT